Colin Ivor Johnston
#126,512
Most Influential Person Now
Colin Ivor Johnston's AcademicInfluence.com Rankings
Colin Ivor Johnstonengineering Degrees
Engineering
#4182
World Rank
#5355
Historical Rank
Biomedical Engineering
#245
World Rank
#252
Historical Rank
Colin Ivor Johnstonphilosophy Degrees
Philosophy
#5957
World Rank
#8897
Historical Rank
Logic
#3158
World Rank
#4276
Historical Rank
Download Badge
Engineering Philosophy
Colin Ivor Johnston's Degrees
- Doctorate Medicine Stanford University
Why Is Colin Ivor Johnston Influential?
(Suggest an Edit or Addition)Colin Ivor Johnston's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. (2003) (1114)
- Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly (2018) (665)
- Effect of Aspirin on All‐Cause Mortality in the Healthy Elderly (2018) (511)
- Myocardial infarction increases ACE2 expression in rat and humans. (2005) (381)
- Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy (2003) (347)
- Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. (1998) (344)
- Effect of Aspirin on Disability‐free Survival in the Healthy Elderly (2018) (318)
- ACE2, a new regulator of the renin–angiotensin system (2004) (299)
- Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. (2005) (291)
- The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. (2001) (267)
- Angiotensin receptors: distribution, signalling and function. (2001) (265)
- Angiotensin receptor antagonists: focus on losartan (1995) (234)
- Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. (1992) (233)
- Localization of angiotensin converting enzyme in rat heart. (1991) (211)
- LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSION (1979) (196)
- Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. (2013) (195)
- Brachial Blood Pressure But Not Carotid Arterial Waveforms Predict Cardiovascular Events in Elderly Female Hypertensives (2006) (188)
- Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. (1994) (185)
- ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental Diabetes (2008) (175)
- Reduced osmotic thirst in healthy elderly men. (1991) (152)
- Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. (1999) (141)
- Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report (2002) (134)
- Localization of endothelin receptors in rat kidney. (1989) (120)
- Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study (2017) (117)
- Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors. (1989) (116)
- Neurohumoral responses to chronic myocardial infarction in rats. (1988) (116)
- Vasopressin in circulatory control and hypertension. (1985) (107)
- Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists. (1989) (101)
- INCREASED CARDIAC ANGIOTENSIN‐CONVERTING ENZYME IN RATS WITH CHRONIC HEART FAILURE (1990) (92)
- Decreased cardiac beta-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. (1979) (92)
- Adriamycin cardiomyopathy in the rabbit: an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms. (1985) (90)
- Developmental expression of ACE2 in the SHR kidney: a role in hypertension? (2006) (87)
- Differential renal function during angiotensin converting enzyme inhibition in renovascular hypertension. (1986) (86)
- Optimizing treatment of hypertension in patients with diabetes. (2000) (82)
- Atrial Natriuretic Peptide in Chronic Heart Failure in the Rat: A Correlation with Ventricular Dysfunction (1986) (81)
- Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels. (1982) (81)
- Inhibition of adenylate cyclase by angiotensin II in rat renal cortex. (1982) (81)
- Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat. (1990) (78)
- Disturbed fluid and electrolyte homoeostasis following dehydration in elderly people. (1993) (77)
- Plasma Renin Levels and Vascular Complications in Hypertension (1973) (77)
- Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus. (1998) (76)
- Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography. (1988) (76)
- Inhibition of Angiotensin‐Converting Enzyme (ACE) in Plasma and Tissue (1990) (76)
- Evidence for activation of the renin–angiotensin system in the human prostate: increased angiotensin II and reduced AT1 receptor expression in benign prostatic hyperplasia (2002) (73)
- Identification of angiotensin converting enzyme 2 in the rodent retina (2004) (73)
- The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor. (1988) (72)
- Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly (2003) (72)
- Feasibility of conducting a primary prevention trial of low‐dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study (2008) (71)
- Nervous Kidney Interaction Between Renal Sympathetic Nerves and the Renin-Angiotensin System in the Control of Renal Function (2000) (68)
- Restoration of Suppressed Baroreflex Sensitivity in Rats with Hereditary Diabetes Insipidus (Brattleboro Rats) by Arginine‐Vasopressin and DDAVP (1983) (68)
- High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage. (2012) (68)
- The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels (1975) (68)
- Controlled trial of enalapril in congestive cardiac failure. (1985) (67)
- Effects of drinking on thirst and vasopressin in dehydrated elderly men. (1993) (66)
- Similar Effects of Treatment on Central and Brachial Blood Pressures in Older Hypertensive Subjects in the Second Australian National Blood Pressure Trial (2007) (66)
- Decreased Atrial Natriuretic Peptide Binding in Renal Medulla in Rats With Chronic Heart Failure (1988) (66)
- CHANGES IN CARDIAC ANGIOTENSIN CONVERTING ENZYME AFTER MYOCARDIAL INFARCTION AND HYPERTROPHY IN RATS (1991) (65)
- Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy (2003) (64)
- Isolation of renin granules from rat kidney cortex and evidence for an inactive form of renin (prorenin) in granules and plasma. (1976) (64)
- Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat. (1994) (62)
- Changes in Tissue Alphaand Beta‐Adrenergic Receptors in Renal Hypertension in the Rat (1980) (61)
- Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia. (2001) (60)
- Role of vasopressin in cardiovascular homeostasis and hypertension. (1981) (60)
- Angiotensin converting enzyme (ACE), characterization by 125I-MK351A binding studies of plasma and tissue ACE during variation of salt status in the rat. (1986) (60)
- Atrial natriuretic peptide is a physiological inhibitor of ACTH release: evidence from immunoneutralization in vivo. (1991) (59)
- Intrarenal renin-angiotensin system in renal physiology and pathophysiology. (1993) (59)
- ANGIOTENSIN CONVERTING ENZYME INHIBITION IN RENOVASCULAR HYPERTENSION: FREQUENCY OF REVERSIBLE RENAL FAILURE (1984) (59)
- Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. (1981) (59)
- Preclinical pharmacology of angiotensin II receptor antagonists: update and outstanding issues. (1997) (58)
- Contribution of vasopressin to the maintenance of blood pressure during dehydration. (1983) (58)
- REDUCED VASCULAR RESPONSE TO ANGIOTENSIN II IN SECONDARY HYPERALDOSTERONISM. (1963) (57)
- Metabolism of Angiotensin II In Sodium Depletion and Hypertension in Humans (1972) (57)
- Renin, Angiotensin II, and Adrenal Corticosteroid Relationships during Sodium Deprivation and Angiotensin Infusion in Normotensive and Hypertensive Man (1972) (57)
- Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment. (1991) (54)
- Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit. (1986) (53)
- Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. (1997) (53)
- The cardiac renin-angiotensin system in heart failure. (1993) (52)
- Specific Changes in Hypothalamic Alpha‐Adrenoceptors in Young Spontaneously Hypertensive Rats (1981) (51)
- Acute renal haemodynamic and renin‐angiotensin system responses to graded renal artery stenosis in the dog. (1979) (50)
- Biological Significance of Renin Angiotensin Immunization (1970) (50)
- Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism. (1995) (50)
- Acute Angiotensin 11‐Media ted Restoration of Distal Renal Artery Pressure in Renal Artery Stenosis and its Relationship to the Development of Sustained One‐Kidney Hypertension in Conscious Dogs (1979) (50)
- KALLIKREIN AND PLASMIN AS ACTIVATORS OF INACTIVE RENIN (1978) (49)
- Amylin stimulates plasma renin concentration in humans. (1995) (49)
- Vasopressin stimulates phosphatidylinositol turnover and aldosterone synthesis in rat adrenal glomerulosa cells: comparison with angiotensin II. (1986) (47)
- Inhibition of adenylate cyclase in rat adrenal glomerulosa cells by angiotensin II. (1984) (47)
- ANGIOTENSIN CONVERTING ENZYME IN THE RAT HEART: STUDIES OF ITS INHIBITION IN VITRO AND EX VIVO (1989) (46)
- Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors. (1988) (46)
- Plasma vasopressin in blood pressure homeostasis and in experimental renal hypertension. (1980) (45)
- VALIDATION OF AN ECHOCARDIOGRAPHIC ASSESSMENT OF CARDIAC FUNCTION FOLLOWING MODERATE SIZE MYOCARDIAL INFARCTION IN THE RAT (1996) (44)
- Antihypertensive and antihypertrophic effects of omapatrilat in SHR. (2000) (44)
- Smaller Aortic Dimensions Do Not Fully Account for the Greater Pulse Pressure in Elderly Female Hypertensives (2008) (43)
- Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat. (1998) (43)
- EVALUATION OF RENIN AND ANGIOTENSIN ASSAYS AND THEIR CLINICAL APPLICATION (1971) (43)
- Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs (2000) (42)
- Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia. (2001) (42)
- Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney. (1988) (42)
- Renin substrate in granules from rat kidney cortex. (1976) (42)
- Biochemistry and Pharmacology of the Renin-Angiotensin System (2012) (42)
- Hormonal Responses to Angiotensin Blockade: Comparison between Receptor Antagonism and Converting Enzyme Inhibition (1980) (41)
- Australian comparative outcome trial of angiotensin-converting enzyme inhibitor- and diuretic-based treatment of hypertension in the elderly (ANBP2): objectives and protocol. Management Committee on behalf of the High Blood Pressure Research Council of Australia. (1997) (41)
- PLASMA ATRIAL NATRIURETIC PEPTIDE: CONCENTRATIONS AND CIRCULATING FORMS IN NORMAL MAN AND PATIENTS WITH CHRONIC RENAL FAILURE (1987) (41)
- Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats (1990) (41)
- REVERSAL OF DIGITALIS INTOXICATION BY BETA-ADRENERGIC BLOCKADE WITH PRONETHALOL. (1964) (41)
- Evaluation of Angiotensin Converting Enzyme (ACE) in the Pharmacokinetics and Pharmacodynamics of ACE Inhibitors (1986) (41)
- 1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1989) (41)
- Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension. (1984) (40)
- Differential angiotensin-converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography. (1988) (40)
- Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients. (1981) (40)
- Vasopressin receptor antagonism — a therapeutic option in heart failure and hypertension (2000) (40)
- Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition. (1983) (39)
- [125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors. (1989) (39)
- Salt Blocks the Renal Benefits of Ramipril in Diabetic Hypertensive Rats (1991) (38)
- EFFECTS OF POSTURE ON CIRCULATING ATRIAL NATRIURETIC PEPTIDE (1985) (37)
- In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the rat. (1999) (37)
- Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition. (2002) (37)
- Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes (2002) (36)
- The role of vasopressin in blood pressure control and in experimental hypertension. (1978) (36)
- Stimulation of phosphatidylinositol metabolism in atrial and ventricular myocytes. (1986) (36)
- Localization of angiotensin‐converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia (2001) (36)
- Plasma vasopressin and human neurophysins in physiological and pathological states associated with changes in vasopressin secretion. (1979) (36)
- Atrial natriuretic peptide is involved in the ACTH response to stress and glucocorticoid negative feedback in the rat. (1992) (35)
- Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats. (1976) (34)
- Vascular responses to vasopressin antagonists in man and rat. (1994) (34)
- Beneficial Renal and Cardiac Effects of Vasopeptidase Inhibition With S21402 in Heart Failure (2000) (34)
- Contribution of stenosis resistance to the rise in total peripheral resistance during experimental renal hypertension in conscious dogs. (1981) (33)
- Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies. (1992) (33)
- Atrial natriuretic factor in normal man: effects of tilt, posture, exercise and haemorrhage. (1986) (32)
- In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan. (2000) (31)
- Mechanism of progression of renal disease: current hemodynamic concepts. (1998) (31)
- Renin-Angiotensin System, Adrenal Steroids and Sodium Depletion in a Primitive Mammal, the American Opossum1 (1967) (30)
- Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme. (1994) (30)
- PRESERVATION OF RENAL FUNCTION IN THE RAT REMNANT KIDNEY MODEL OF CHRONIC RENAL FAILURE BY BLOOD PRESSURE REDUCTION (1986) (30)
- Enalapril (MK421) activation in man: importance of liver status. (1985) (30)
- Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade. (1996) (30)
- Demonstration of adenylate cyclase coupled adenosine receptors in guinea pig ventricular membranes. (1983) (29)
- Reduced vascular beta-adrenergic receptors in deoxycorticosterone-salt hypertensive rats. (1980) (29)
- ACUTE AND CHRONIC EFFECTS OF ANGIOTENSIN‐CONVERTING ENZYME INHIBITORS ON TISSUE ANGIOTENSIN‐CONVERTING ENZYME (1992) (29)
- Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase. (1989) (29)
- Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice (2005) (29)
- The contribution of vasopressin and angiotensin to the maintenance of blood pressure after autonomic blockade. (1985) (29)
- Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat. (1987) (29)
- Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement. (1988) (29)
- Role of vasopressin in hypertension: studies using the Brattleboro rat. (1982) (28)
- Effects of Perindopril on Tissue Angiotensin‐Converting Enzyme Activity Demonstrated by Quantitative in vitro Autoradiography (1988) (28)
- Plasma renin and angiotensin levels in experimental hypertension in the rat. (1975) (28)
- SEQUENTIAL CHANGES IN CIRCULATING LEVELS OF ANGIOTENSIN I AND II, RENIN, AND BRADYKININ AFTER CAPTOPRIL (1979) (28)
- Angiotensin II Receptor Antagonists (1997) (27)
- Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension. (1984) (27)
- Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7). (2012) (27)
- THE TISSUE RENIN‐ANGIOTENSIN SYSTEM AND ITS FUNCTIONAL ROLE (1992) (27)
- Rationale and pharmacology of angiotensin II receptor antagonists: current status and future issues. (1997) (26)
- ROLE OF THE KALLIKREIN‐KININ SYSTEM IN THE RENAL EFFECTS OF ANGIOTENSIN‐CONVERTING ENZYME INHIBITION IN ANAESTHETIZED DOGS (1981) (26)
- Attenuated response to atrial natriuretic peptide in rats with myocardial infarction. (1989) (26)
- Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril. (1988) (26)
- Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension. (1979) (25)
- The renin-angiotensin system in acute renal failure in rats. (1974) (25)
- Atrial natriuretic peptide in dehydrated Long-Evans rats and Brattleboro rats. (1987) (25)
- A review of plasma renin measurements and their clinical significance. (1971) (24)
- Mechanism for hypotensive action of angiotensin converting enzyme inhibitors. (1984) (24)
- Angiotensin‐Converting Enzyme Inhibition: Prospects for the Future (1991) (23)
- Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats (1997) (23)
- Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine. (1982) (23)
- Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR. (1997) (22)
- Evidence for atrial natriuretic peptide-(5-28) production by rat placental cytotrophoblasts. (1992) (22)
- Involvement of vasopressin in the cardiovascular effects of intracerebroventricularly administered alpha 1-adrenoceptor agonists in the conscious rat. (1985) (22)
- Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone. (1993) (22)
- In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat (2001) (22)
- Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat. (1998) (21)
- α-Adrenergic receptors modulate β-receptor affinity in rat kidney membranes (1980) (21)
- Tissue-specific control of glandular kallikreins. (1984) (21)
- BLOCKADE OF ANGIOTENSIN CONVERTING ENZYME IN CIRCUMVENTRICULAR ORGANS OF THE BRAIN AFTER ORAL LISINOPRIL ADMINISTRATION DEMONSTRATED BY QUANTITATIVE IN VITRO AUTORADIOGRAPHY (1987) (21)
- CHANGES IN ENDOGENOUS CIRCULATING ANGIOTENSIN AND BRADYKININ AFTER INHIBITION OF CONVERTING ENZYME (KININASE II) (1979) (21)
- Neuroendocrine mechanisms and cardiovascular homeostasis in the elderly (2004) (21)
- OR-26: Diabetes and cardiovascular outcomes in elderly subjects treated with ace-inhibitors or diuretics: findings from the 2ND Australian national blood pressure study (2003) (21)
- Evolution of blockade of the renin-angiotensin system. (1995) (21)
- Effect of inhibition of converting enzyme on inactive renin in the circulation of salt-replete and salt-deplete normal subjects. (1980) (21)
- Angiotensin converting enzyme inhibition in plasma and tissues. (1987) (20)
- Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure study. (2014) (20)
- Selective inhibition by epinephrine of parathyroid hormone-stimulated adenylate cyclase in rat renal cortex. (1982) (20)
- Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495. (1997) (20)
- Characterization of immunoreactive angiotensin in canine cerebrospinal fluid as Des-Asp1-angiotensin II. (1978) (20)
- CHARACTERIZATION OF ANGIOTENSIN CONVERTING ENZYME FROM RAT TISSUE BY RADIO‐INHIBITOR BINDING STUDIES (1986) (19)
- Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension. (1982) (19)
- Angiotensin‐Converting Enzyme Inhibitors: Measurement of Relative Inhibitory Potency and Serum Drug Levels by Radioinhibitor Binding Displacement Assay (1987) (19)
- Vasopressin receptors in rat brain and kidney: studies using a radio‐iodinated V1 receptor antagonist (1988) (19)
- Who's really hypertensive? – Quality control issues in the assessment of blood pressure for randomized trials (2005) (19)
- Contribution of vasopressin to the maintenance of blood pressure in deoxycorticosterone-salt induced malignant hypertension in spontaneously hypertensive rats. (1986) (19)
- Adenosine receptors in papilla of human kidneys. (1986) (19)
- Halothane hepatitis in a laboratory technician. (1971) (18)
- Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. (2002) (18)
- Emergency Treatment of Severe Hypertension with Intravenous Labetalol (1978) (18)
- A Comparison Between the Adenosine Receptors Mediating Adenylate Cyclase Inhibition and Cardiac Depression in the Guinea Pig Heart (1986) (18)
- Lisinopril pharmacokinetics in chronic renal failure. (1988) (18)
- Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat (2001) (18)
- Use of captopril in the diagnosis of renal hypertension. (1981) (17)
- Reduction of endothelin levels by the dihydropyridine calcium antagonist nisoldipine and a 'natural factor' in cultured human endothelial cells (1993) (17)
- Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the rat. (2003) (17)
- Demonstration of RA - adenosine receptors in rat renal papillae. (1984) (17)
- Release of active and inactive kallikrein from the isolated perfused rat kidney. (1984) (17)
- Alpha-adrenergic inhibition of renal cortical adenylate cyclase. (1980) (17)
- Effect of angiotensin-converting enzyme inhibition on renal filtration surface area in hypertensive rats. (2001) (17)
- Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat. (1993) (17)
- Meeting report of the International Society of Hypertension Conference on Hypertension and Diabetes. (1992) (17)
- Lack of effect of atrial natriuretic peptide on vasopressin release. (1987) (17)
- Regulation of cardiac preload by atrial natriuretic peptide in congestive cardiac failure. (1988) (16)
- Synergistic effect of nisoldipine and nitroglycerin on human internal mammary artery. (1994) (16)
- Thirst and Fluid Intake in the Elderly (1991) (16)
- Hypotensive effect of ZD7155, an angiotensin II receptor antagonist, parallels receptor occupancy in two‐kidney, one‐clip Goldblatt hypertensive rats (1998) (16)
- Specific Increase in Renal αl-Adrenergic Receptors Following Unilateral Renal Denervation (1985) (16)
- Vasopressin and angiotensin II contribute equally to the increased afterload in rabbits with heart failure. (1991) (16)
- Lack of cross sensitivity between captopril and enalapril. (1988) (15)
- The physiological release of specific individual neurophysins into the circulation of pigs. (1977) (15)
- New hormonal blockade strategies in cardiovascular disease. (1998) (15)
- A radiochemical renin assay. (1971) (15)
- Comparative in vivo effects of irbesartan and losartan on angiotensin II receptor binding in the rat kidney following oral administration. (2000) (15)
- RELATIVE INHIBITORY POTENCY AND PLASMA DRUG LEVELS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN THE RAT (1988) (15)
- Characterization of angiotensin converting enzyme in isolated cerebral microvessels from spontaneously hypertensive and normotensive rats (1992) (14)
- Comparison of renin-angiotensin to calcium channel blockade in renal disease. (1997) (14)
- Solubilization and characterization of endothelin-1 receptors in rat cardiac tissue. (1990) (14)
- Spectrum of use for the angiotensin-receptor blocking drugs (1999) (14)
- Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic Concept (2000) (14)
- Systemic and regional effects of vasopressin and angiotensin in acute left ventricular failure. (1991) (14)
- Age-dependent regulation of renal vasopressin V(1A) and V₂ receptors in rats with genetic hypertension: implications for the treatment of hypertension. (2013) (14)
- Treatment of hypertension with angiotensin converting enzyme inhibitors. (1982) (14)
- Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260). (1994) (13)
- Angiotensin-converting enzyme (ACE) measurement in human serum using radioinhibitor ligand binding. (1986) (13)
- Cardiac Hypertrophy and Salt Status in Chronic Myocardial Infarction in the Rat: Effects of Enalapril Versus Salt Restriction (1988) (13)
- Chronic angiotensin converting enzyme inhibition in the two‐kidney, one clip hypertensive rat (1988) (13)
- ACUTE CHANGES IN BLOOD PRESSURE AND VASOACTIVE HORMONES AFTER CAPTOPRIL IN HYPERTENSIVE PATIENTS (1980) (13)
- Radioimmunoassay of blood bradykinin: purification of blood extracts to prevent cross-reaction with endogenous kininogen. (1983) (13)
- Clonidine in the treatment of hypertension. (1971) (13)
- Second Australian National Blood Pressure Study (ANBP2) - Comparative outcome trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly: Principal results (2003) (13)
- Autologous neutrophil derived supernatants inhibit endothelium dependent relaxation in human coronary bypass graft. (1994) (13)
- Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor. (1992) (13)
- EFFECTS OF CALCIUM‐ AND ETa‐RECEPTOR ANTAGONISTS ON ENDOTHELIN‐INDUCED VASOCONSTRICTION AND LEVELS OF ENDOTHELIN IN THE HUMAN INTERNAL MAMMARY ARTERY (1994) (13)
- Measurement of angiotensin converting enzyme inhibitors in serum by radioinhibitor binding displacement assay. (1987) (13)
- Changes in the renin-angiotensin system, exchangeable body sodium, and plasma and atrial content of atrial natriuretic factor during evolution of chronic renal failure in the rat. (1988) (13)
- Renovascular hypertension: treatment with the oral angiotensin-converting enzyme inhibitor enalapril. (1986) (12)
- ENDOGENOUS VASOPRESSIN MODULATES THE BAROREFLEX SENSITIVITY IN RATS (1983) (12)
- INTRARENAL ACTION OF ANGIOTENSIN II IN RESTORING RENAL ARTERY PRESSURE AFTER ACUTE RENAL ARTERY STENOSIS (1978) (12)
- REGULATION OF UTERINE SMOOTH MUSCLE BRADYKININ RECEPTORS BY BRADYKININ LEVELS AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR IN THE RAT (1981) (12)
- The boundaryless hospital--a commentary. (1995) (12)
- Renin release from isolated rat glomeruli. (1976) (12)
- Negative cooperativity of rat kidney beta-adrenergic receptors. (1980) (12)
- Change in Blood Pressure Variability Among Treated Elderly Hypertensive Patients and Its Association With Mortality (2019) (12)
- Plasma renin and angiotensin levels in human hypertension following treatment. (1973) (11)
- Role of Vasopressin in Experimental Congestive Cardiac Failure (1986) (11)
- ATRIAL NATRIURETIC FACTOR IN CHRONIC RENAL FAILURE: STUDIES IN MAN AND THE RAT (1987) (11)
- Responses of vasoactive hormones in congestive cardiac failure. (1987) (11)
- HUMAN INTERNAL MAMMARY ARTERY RESPONSES TO NON‐PEPTIDE VASOPRESSIN ANTAGONISTS (1994) (11)
- Clearance and metabolism of neurophysins by rat kidney. (1975) (11)
- DISTRIBUTION AND INHIBITION OF NEUTRAL METALLOENDOPEPTIDASE (NEP) (EC 3.4.24.11), THE MAJOR DEGRADATIVE ENZYME FOR ATRIAL NATRIURETIC PEPTIDE, IN THE RAT KIDNEY (1991) (11)
- Plasma Atrial Natriuretic Factor in Pregnancy (1987) (11)
- Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels during perindopril therapy of chronic left ventricular failure in rats. (1989) (11)
- Regulation of angiotensin II receptors in the prostate of the transgenic (mRen-2)27 rat: effect of angiotensin-converting enzyme inhibition. (2003) (11)
- Cardiomegaly and vasoactive hormones in rats with chronic myocardial infarction: long-term effects of chlorothiazide. (1996) (11)
- RENAL, ADRENAL AND VASCULAR CHANGES DURING INHIBITION OF CONVERTING ENZYME WITH CAPTOPRIL (1980) (10)
- Angiotensin AT4 receptors in the normal human prostate and benign prostatic hyperplasia (2001) (10)
- Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarction. (1998) (10)
- Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertension. (1997) (10)
- Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury. (1989) (10)
- COMPARISON OF THE HORMONAL EFFECTS OF CAPTOPRIL (SQ 14225) AND HYDROCHLOROTHIAZIDE IN THE TREATMENT OF ESSENTIAL HYPERTENSION (1979) (10)
- Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease prevention. (2008) (10)
- Cardiac angiotensin converting enzyme and endothelin receptor in rats with chronic myocardial infarction. (1996) (10)
- Renal proximal tubular alpha-adrenergic receptors oppose urinary 3,5'-cyclic adenosine monophosphate response to parathyroid hormone in vivo. (1985) (10)
- ANGIOTENSIN‐CONVERTING ENZYME IN MACRO‐AND MICROVESSELS OF THE RAT (1991) (10)
- Molecular cloning and sequencing of the gene encoding a sheep arginine vasopressin type 1a receptor. (1995) (9)
- Effect of chronic neutral endopeptidase inhibition on cardiac hypertrophy after experimental myocardial infarction. (1998) (9)
- 1 Angiotensin II receptor antagonist (D7155) blocks angiotensin II binding in vivo and lowers blood pressure (1993) (9)
- THE NEPHROTIC SYNDROME IN PREGNANCY. (1963) (9)
- Pharmacology of irbesartan. (1999) (9)
- Inhibition of kidney neutral endopeptidase after administration of the neutral endopeptidase inhibitor candoxatril: quantitation by autoradiography. (1998) (9)
- Are calcium antagonists of value in ameliorating the course of chronic renal disease? (1992) (9)
- Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels in a rat model of left ventricular failure. (1989) (9)
- Specific increase in renal alpha 1-adrenergic receptors following unilateral renal denervation. (1985) (9)
- Tissue Angiotensin Converting Enzyme (ACE) During Changes in the Renin—Angiotensin System (1987) (9)
- Renin release in chronic paraplegia. (1971) (9)
- Renovascular Hypertension Structural Changes in the Renal Vasculature (2000) (8)
- Effects of perindopril on angiotensin converting enzyme in tissues of the rat. (1988) (8)
- Evidence for cardioprotective, renoprotective, and vasculoprotective effects of vasopeptidase inhibitors in disease (2001) (8)
- REDUCTION IN LEFT VENTRICULAR MASS IN NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS GIVEN ENALAPRIL (1991) (8)
- Decreased Cardiac β‐Adrenergic Receptors in Deoxycorticosterone‐Salt and Renal Hypertensive Rats (1979) (8)
- THE USE OF CLONIDINE (“CATAPRES”) IN THE TREATMENT OF HYPERTENSION (1970) (8)
- The preparation and purification of 3–(4‐iodophenoxy)‐1‐isopropylamino‐2‐propanol‐125I, a beta adrenergic antagonist (1977) (8)
- PHARMACOKINETICS OF ANGIOTENSIN CONVERTING ENZYME INHIBITION IN TISSUES FOLLOWING ORAL LISINOPRIL: STUDIES IN THE RAT USING QUANTITATIVE RADIOINHIBITOR BINDING (1987) (8)
- Acute and chronic effects of perindopril on tissue angiotensin converting enzyme activity. (1991) (8)
- Identification of "angiotensin immunoreactive material" in rat kidney. (1977) (8)
- Vasopressin V1a and V2 receptor mRNA in deoxycorticosterone acetate-salt hypertension in the rat. (1998) (8)
- Erratum: ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes (Diabetes (2008) 57 (1018-1025)) (2011) (8)
- MESENTERIC RESISTANCE AND BRAIN MICROVASCULAR ANGIOTENSIN‐CONVERTING ENZYME IN THE SPONTANEOUSLY HYPERTENSIVE RAT (1992) (8)
- Malignant Hypertension in Brattleboro (Vasopressin‐deficient) Rats (1983) (8)
- Steady‐State Pharmacokinetics and Pharmacodynamics of Cilazapril in the Presence and Absence of Cyclopenthiazide (1992) (7)
- Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition. (1980) (7)
- Vascular albumin permeability and hypertrophy in a rat model combining streptozotocin-induced diabetes and genetic hypertension (1995) (7)
- Reduced Oropharyngeal Inhibition of AVP Secretion in Dehydrated Elderly Men a (1993) (7)
- Angiotensin II type 1 receptor blockade: a novel therapeutic concept. (2000) (7)
- Angiotensin AT(4) receptors in the normal human prostate and benign prostatic hyperplasia. (2001) (7)
- Clinical improvement and hormonal changes in severe cardiac failure after captopril treatment. (1981) (7)
- EFFECTS OF CAPTOPRIL (SQ14225) ON BLOOD PRESSURE AND CIRCULATING VASOACTIVE HORMONES IN PATIENTS WITH ESSENTIAL HYPERTENSION (1980) (6)
- Potent inhibitory effect of SR 49059, an orally active non-peptide vasopressin VIa receptor antagonist, on human arterial coronary bypass graft. (1995) (6)
- Modulation of the Renin–Angiotensin System by Atrial Natriuretic Peptide (1990) (6)
- Tachycardic and hypertensive effects of centrally administered clonidine in conscious rats. (1986) (6)
- CARDIAC HYPERTROPHY IN DIABETIC SPONTANEOUSLY HYPERTENSIVE RATS: ROLE OF ANGIOTENSIN II? (1997) (6)
- Influences of low sodium diets on vascular effects of bradykinin and on bradykinin receptors in the uterine smooth muscle in the rats. (1982) (6)
- FEASIBILITY OF CONDUCTING CARDIOVASCULAR OUTCOME RESEARCH IN AUSTRALIAN GENERAL PRACTICE: RESULTS FROM THE ANBP2 PILOT STUDY (1997) (6)
- Adrenal angiotensin II receptors and vascular reactivity to angiotensin II in the rat during continuous inhibition of angiotensin converting enzyme. (1980) (6)
- A TWO‐SITE MONOCLONAL IMMUNORADIOMETRIC ASSAY FOR TOTAL RENIN PROTEIN: COMPARISON WITH AN ESTABLISHED ENZYME KINETIC ASSAY (1988) (6)
- VARIATION IN ANGIOTENSIN‐CONVERTING ENZYME (ACE) INHIBITOR AFFINITY AT TWO BINDING SITES ON RAT PULMONARY ACE: INFLUENCE ON BRADYKININ HYDROLYSIS (1992) (6)
- Atrial Natriuretic Peptide Infusion in Chronic Heart Failure in the Rat (1988) (6)
- Effects of Neutral Endopeptidase Inhibition in the Rat Remnant Kidney Model (1998) (5)
- Neurohormonal antagonism in heart failure ; beneficial effects of vasopressin V and V receptor blockade and ACE inhibition 1 a 2 * (2002) (5)
- Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study. (2019) (5)
- C008: Opera: Design and rationale for a novel placebo control trial testing the benefits of blood pressure reduction in patients with stage I isolated systolic hypertension (2000) (5)
- Future Management of High Blood Pressure (1996) (5)
- Pharmacology of Agents Acting on the Renin-Angiotensin System (1983) (5)
- Effect of Ureteral Ligation on Blood Pressure and Renin Content of the Kidneys in Renal Hypertensive Rats (1968) (5)
- Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225). (1979) (5)
- Role of Vasopressin in Blood Pressure Regulation Through its Modulatory Effect on Baroreceptor Reflex (1984) (5)
- Treatment of hypertension with angiotensin converting enzyme inhibitors. (1984) (5)
- Characterisation of angiotensin converting enzyme from different rat vascular beds. (1995) (5)
- Bradykinin receptors in rat uterine smooth muscle: studies using radiolabeled ligand binding. (1984) (4)
- The place of diuretics in the treatment of hypertension in 1993: can we do better? (1993) (4)
- Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: a cross-sectional study. (2019) (4)
- HIGH SALT DIET AMELIORATES EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITION IN SPONTANEOUSLY HYPERTENSIVE STREPTOZOTOCIN DIABETIC RATS (1990) (4)
- Atrial natriuretic peptide and total exchangeable body sodium: relationships in rats with chronic myocardial infarction. (1988) (4)
- Investigation of cardiac beta-adrenoceptors using 125I-labelled 1-(4-iodophenoxy)-3-isopropylaminopropan-2-ol. (1978) (4)
- Decreased uterine bradykinin receptors during captopril infusion in rats. (1982) (4)
- Angiotensin converting‐enzyme inhibitors — the balance sheet (1988) (4)
- Beyond ACE inhibition: new developments in drug therapy for hypertension (1995) (4)
- Cardiac and renal hypertrophy is independent of tissue angiotensin converting enzyme and circulating angiotensin II in hypertensive rats. (1991) (4)
- Corrigendum: Baseline characteristics of participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study (Journals of Gerontology - Series A Biological Sciences and Medical Sciences DOI: 10.1093/gerona/glw342) (2019) (4)
- Angiotensin converting enzyme inhibitors: differences and advantages for first line therapy in hypertension. (1989) (4)
- In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a dual vasopeptidase inhibitor (1999) (3)
- Hypertension as a Risk Factor for Stroke Subtypes (1994) (3)
- A stable leukocyte-derived factor inhibits platelet aggregation. (1994) (3)
- HAEMODYNAMIC, RENAL AND HORMONAL RESPONSES TO ENALKIREN IN FOUR PATIENTS WITH POST‐SURGICAL OLIGURIA (1994) (3)
- Cardiovascular Adrenergic Receptors in Experimental Hypertension in the Rat (1980) (3)
- Angiotensin converting enzyme inhibitors in perspective: an update. (1993) (3)
- CHARACTERIZATION OF MONOCLONAL ANTIBODIES TO A RAT LIVER VASOPRESSIN RECEPTOR (1991) (3)
- ATTENUATED RENAL RESPONSE TO ATRIAL NATRIURETIC PEPTIDE INFUSION IN RATS WITH HEART FAILURE (1988) (2)
- Renin measurement in blood collected from the efferent arteriole of the kidney of the rat (2004) (2)
- Chapter 9 – Angiotensin-Converting Enzymes: Properties and Function (2005) (2)
- Evidence for the implication of endogenous vasopressin in cardiovascular response to central alpha-adrenoceptor stimulation. (1986) (2)
- PATHOPHYSIOLOGICAL RATIONALE FOR THE USE OF VASODILATORS IN HYPERTENSION (1975) (2)
- Vasoactive peptides and hypertension: role of angiotensin converting enzyme. (1981) (2)
- Alpha-Adrenergic receptors modulate beta-receptor affinity in rat kidney membranes. (1980) (2)
- DEMONSTRATION OF PROXIMAL TUBULAR α‐ADRENOCEPTORS IN VIVO (1984) (2)
- Pharmacokinetics of angiotensin converting enzyme inhibitors in plasma and tissue using radioinhibitor binding and displacement assays. (1989) (2)
- Induction of Ca2+ signaling and possible exocytosis in endothelial cells by a stable leukocyte-derived factor. (1995) (2)
- Medullary thyroid carcinoma: a functional peptidesecreting tumour. (1970) (2)
- Congestive cardiac failure and arrhythmias (1995) (2)
- DECREASED CARDIAC BETA-ADRENERGIC RECEPTORS IN HYPERTENSIVE RATS (1979) (2)
- ACE inhibitors and the kidney. (1990) (2)
- Angiotensin converting enzyme inhibitors: drug interactions. (1987) (2)
- VASCULAR LESIONS AND ANGIOTENSIN IN MALIGNANT HYPERTENSION IN THE ABSENCE OF VASOPRESSIN (1982) (2)
- New Pharmacologic Approaches to the Management of Hypertension Introduction (1997) (1)
- Pharmacological management of chronic heart failure (CHF) in Australian general practice: tthe cardiac awareness survey and evaluation (case) study (1999) (1)
- Lisinopril pharmacokinetics inchronic renal failure (1988) (1)
- Angiotensin receptor antagonists for the treatment of hypertension (1998) (1)
- 28 Deoxycorticosterone-salt hypertension: effect of a non-peptide arginine vasopressin V1-receptor antagonist (1993) (1)
- Renal kinins and renal haemodynamics. (1983) (1)
- Persistent postural hypotension due to guanacline (1969) (1)
- Australasian contributions to research into hypertension. (1988) (1)
- Predictors of failure to initiate randomized treatment in a large trial of antihypertensive drug therapy in the aged. (2005) (1)
- 154. Comparative study of angiotensin converting enzyme induction and inhibition in rat tissue and plasma after chronic treatment with enalapril and quinapril (1991) (1)
- IMPORTANCE OF ENDOGENOUS VASOPRESSIN IN THE HYPERTENSIVE AND BRADYCARDIC RESPONSE TO CENTRAL α1‐ADRENERGIC STIMULATION (1985) (1)
- Hypotensive effect of captopril and decreased rat uterine bradykinin receptors. (1984) (1)
- ISOLATION AND CHARACTERIZATION OF THE RAT LIVER AVP RECEPTOR USING [125I][d(CH2)5′SARCOSINE7]AVP1 (1992) (1)
- Defining moments in medicine. Internal medicine. (2001) (1)
- ATRIAL NATRIURETIC PEPTIDE RELEASE IN THE RABBIT IS INDEPENDENT OF CARDIAC NERVE ACTIVITY (1987) (1)
- Role of Prostaglandins in the Renal Response to Angiotensin‐Converting Enzyme Inhibition and Renal Artery Occlusion (1983) (1)
- Effect of Antihypertensive Drugs on the Renin-Angiotensin System (2012) (1)
- Atrial natriuretic peptide (ANP) is a physiological inhibitor of adrenocorticotrophin (ACTH) secretion in the rat (1992) (1)
- RENAL HYPERTENSION IN THE BRATTLEBORO DIABETES INSIPIDUS RAT * (1982) (1)
- Clinic and ambulatory blood pressure relationships to outcome in the Second Australian National Blood Pressure Study (ANBP2): What do we mean by "clinic blood pressure"? (2008) (0)
- Selective adrenal venography in the investigation of primary aldosteronism. (1975) (0)
- Cholesterol Complacency in Australia: Implications for Heart Disease Prevention (2007) (0)
- Second Australian national blood pressure study (ANBP2) — progress report (2001) (0)
- SP 01-3 ALDOSTERONE ANTAGONISTS IN HEART FAILURE. (2016) (0)
- Felodipine compared to prazosin as additional therapy to a beta-blocking drug. (1987) (0)
- INHIBITION OF ANGIOTENSIN CONVERTING ENZYME (ACE): AN ADVANCE IN THE TREATMENT OF SEVERE CONGESTIVE HEART FAILURE (1982) (0)
- Everything you wanted to know about high blood pressure (1998) (0)
- Modern concepts in the management of congestive cardiac failure (1989) (0)
- SP 01-3 ALDOSTERONE ANTAGONISTS IN HEART FAILURE. (2016) (0)
- Erratum: Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus: Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade (American Journal of Hypertension (1996; 9:895-901) (1996) (0)
- Hormonal aspects of cardiac hypertrophy and failure (1986) (0)
- Eulogy John Ludbrook: Surgeon, physiologist and biostatistician (2017) (0)
- V1-like [Arg8]vasopressin binding sites occur in rat hepatocyte nuclei. (1994) (0)
- Interaction between vasopressin and renin-angiotensin system in experimental hypertension (1981) (0)
- Dual neutral endopeptidase/angiotensin converting enzyme inhibition in rats with hypertension and diabetes mellitus (1998) (0)
- Vasopressin V2 receptor blockade with SR121463 improves left ventricular remodeling in a rat model of heart failure (2003) (0)
- Combined neutral endopeptidase and angiotensin-converting enzyme inhibition attenuates left ventricular remodeling without hypotension in a rat coronary artery ligation model of heart failure (1999) (0)
- P4557Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: a cross-sectional study (2019) (0)
- New antihypertensive drugs. Angiotensin converting enzyme inhibitors and calcium antagonists. (1984) (0)
- Microsoft Word - NEF001BF.rtf (2008) (0)
- FESTSCHRIFT TO EMERITUS PROFESSOR AUSTIN E. DOYLE AN AUSTRALIAN VIEW (1988) (0)
- NEUROPHYSINS: POSTERIOR PITUITARY PROTEINS—‐THEIR PHYSIOLOGICAL ROLE (1977) (0)
- Vasoactive peptides in experimental renal hypertension (2005) (0)
- Results of ASPREE feasibility study (2005) (0)
- Final results of the ASPREE feasibility trial (2006) (0)
- MONOCLONAL ANTIBODIES TO ARGININE VASOPRESSIN RECEPTOR BIND TO LIVER, KIDNEY AND PITUITARY MEMBRANES (1993) (0)
- P6362Impact of the 2017 AHA/ACC hypertension guideline on hypertension prevalence and cardiovascular risk factors in a healthy older cohort (2019) (0)
- 24-Hour ACE Inhibition: Current and Future Perspectives: Satellite Symposium to the International Meeting on ACE Inhibition, London, February 1991 (1991) (0)
- 178 Angiotensin-Converting Enzyme Inhibitors in Acute Heart Failure Syndromes: Effect on Inpatient Length of Stay (2011) (0)
- Blockade of the renin angiotensin cascade-an overview (1995) (0)
- Chapter 28 Mode of action of angiotensin converting enzyme inhibitors (1997) (0)
- Internal medicine (2001) (0)
- Comparing ACE inhibitors with diuretics for elderly hypertensives (2003) (0)
- Adrenal angiotensin I 1 receptors and vascular reactivity to angiotensin I 1 in the rat during continuous inhibition of angiotensin converting enzyme (0)
- Appendix : Questionnaire items to determine knowledge and attitudes about cholesterol and adherence to taking cholesterol-lowering medication Presence of cardiovascular risk factors Have you been diagnosed with high blood pressure ? (2009) (0)
- Vasopressin and renin-angiotensin in experimental renal hypertension (1982) (0)
- Regulation of Blood Pressure by Vasopressin (1984) (0)
- Comparative effects of angiotensin converting enzyme inhibition (perindopril) or diuretic therapy on cardiac hypertrophy and sympathetic activity following myocardial infarction in rats (1991) (0)
- ACE Inhibitors at the Kidney: Merck Sharp & Dohme Satellite Symposium, Kyoto, May 1988 (1990) (0)
- Round table 1. Do transgenic techniques help us to understand hypertension? (1993) (0)
- Hormonal and Blood Pressure Responses to Tilting in β-Blocked Essential Hypertension Treated with Felodipine or Prazosin (2012) (0)
- Demonstration of proximal tubular alpha-adrenoceptors in vivo. (1984) (0)
- Renovascular hypertension (1983) (0)
- Angiotensin-Converting Enzyme Inhibitors in the Treatment of Hypertension (1984) (0)
- LVH – A Suitable Case for Treatment (1992) (0)
- Ketanserin combined with a beta-blocker or diuretic in essential hypertension. A multicentre study (2004) (0)
- Kinin receptors in smooth muscle and vascular effects in sodium depleted rats. (1989) (0)
- Sandford Lloyd Skinner (1933–2005) (2005) (0)
- congestive cardiac failure . Controlled trial of enalapril in (0)
- 105. Reduction in left ventricular weight in normotensive Sprague-Dawley and spontaneously hypertensive rats given enalapril (1991) (0)
- Editorial Honoring Colin Johnston (2000) (0)
- O-34: Comparison of omapatrilat to SCH42495 and ramipril in SHR (2001) (0)
- Erratum by the Publisher – Announcement (1999) (0)
- Cardiovascular Effects of Vasopressin (1984) (0)
- New trends in the management of hypertension (1988) (0)
- Letters to the Editor: Angiotensin receptor antagonists (1999) (0)
- The renin system and cardiovascular disease: Lessons from pharmacological intervention (2000) (0)
- In vivo blockade of angiotensin II receptor binding in rat kidney: comparison of candesartan cilexetil with losartan (1999) (0)
- Expensive medical technology (1995) (0)
- Felodipine Compared to Prazosin as Additional Therapy to a β‐Blocking Drug (1987) (0)
- IN VIVO VASOPEPTIDASE INHIBITION: SIMULTANEOUS INHIBITION OF NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN CONVERTING ENZYME BY BMS-189921 (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Colin Ivor Johnston?
Colin Ivor Johnston is affiliated with the following schools:
